QuickView for 5-hydroxytryptamine 3 receptor, A subunit (biogroup)

1. Drug target sets for approved compounds
2. Cooperative Signaling in the STAT3 and NF-kB Pathways in Subtypes of diffuse large B cell lymphoma
3. Gliomas from a mutant EGFR glioma mouse model with induced tumor relapse by removal of mutant EGFR
4. Prostate Cancer Gene Expression in Androgen Receptor and Vitamin D Receptor Mediated Signaling
5. Diffuse large B cell lymphomas linked with outcomes following CHOP chemotherapy

There were no matches for 5-hydroxytryptamine 3 receptor, A subunit

1. Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
2. Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT